Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Schuhmann, H. Rupani, K. Adenji, K. McKinlay, M. Roland (Portsmouth, Basingstoke, Southampton, United Kingdom). Use of FDG-PET in the investigative pathway for lung cancer – real world experience in Southern England. Eur Respir J 2008; 32: Suppl. 52, 1410

Member's Comments

No comment yet.

Related content which might interest you: Towards personalized lung cancer CT screening in Europe Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 Initial experience in the use of PET-CT for the evaluation and follow-up of lung cancer at the Singapore General Hospital Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004 The approach to the surgical management of cancer in four European countries Source: Eur Respir J 2003; 22: 838-844 Year: 2003 An audit on the use of FDG-PET in the diagnosis and management of lung cancer in a district general hospital in the West Midlands, U.K. Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Cytological types of lung cancer in a referral population in Western Greece during the past decade Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Rationalising the lung cancer diagnostic pathway with CT triage; a single centre UK experience. Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 A regional study of bronchoscopic diagnostic yield rates for lung cancer involving centres of the Thames Valley Cancer Network (TVCN), UK Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer Year: 2010 Initial symptoms and diagnostic delays of lung cancer in southern Norway Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006 The impact of specialist lung cancer clinics on government targets in patients referred with suspected lung cancer in the University Hospital of North Staffordshire, UK Source: Eur Respir J 2007; 30: Suppl. 51, 666s Year: 2007 Impact of PET scan on staging and management of lung cancer patients in Indian scenario Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Implementation of lung cancer screening in Europe: the way forward Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 The feasibility of a lung cancer screening program in rural Ireland Source: Eur Respir J 2006; 28: Suppl. 50, 80s Year: 2006 Impact of PET scanning on lung cancer management in a U.K. centre Source: Eur Respir J 2006; 28: Suppl. 50, 83s Year: 2006 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018